HIV vulnerability among adolescent girls and young women: a multi-country latent class analysis approach.
Condom use
Gender equity
IPV
STI
Transactional sex
Journal
International journal of public health
ISSN: 1661-8564
Titre abrégé: Int J Public Health
Pays: Switzerland
ID NLM: 101304551
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
received:
03
06
2019
accepted:
11
03
2020
revised:
06
02
2020
pubmed:
10
4
2020
medline:
18
11
2020
entrez:
10
4
2020
Statut:
ppublish
Résumé
To stem the HIV epidemic among adolescent girls and young women (AGYW, 15-24 years), prevention programs need to reach AGYW who are most at risk. We examine whether individual- and household-level factors could be used to define HIV vulnerability for AGYW. We surveyed out-of-school AGYW in urban and peri-urban Kenya (N = 1014), in urban Zambia (N = 846), and in rural Malawi (N = 1654) from October 2016 to 2017. LCA identified classes based on respondent characteristics, attitudes and knowledge, and household characteristics. Multilevel regressions examined associations between class membership and HIV-related health outcomes. We identified two latent classes-high and low HIV vulnerability profiles-among AGYW in each country; 32% of the sample in Kenya, 53% in Malawi, and 51% in Zambia belonged to the high vulnerability group. As compared to AGYW with a low-vulnerability profile, AGYW with a high-vulnerability profile had significantly higher odds of HIV-related outcomes (e.g., very early sexual debut, transactional sex, sexual violence from partners). Out-of-school AGYW had differential vulnerability to HIV. Interventions should focus on reaching AGYW in the high HIV vulnerability profiles.
Identifiants
pubmed: 32270233
doi: 10.1007/s00038-020-01350-1
pii: 10.1007/s00038-020-01350-1
pmc: PMC7274997
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
399-411Subventions
Organisme : Bill and Melinda Gates Foundation
ID : OPP1136778
Références
Stud Fam Plann. 2018 Dec;49(4):367-383
pubmed: 30478973
AIDS. 2008 Mar 30;22(6):759-66
pubmed: 18356606
J Infect Dis. 2005 Feb 1;191 Suppl 1:S61-7
pubmed: 15627232
J Adolesc Health. 2011 Dec;49(6):559-67
pubmed: 22098766
PLoS One. 2018 Dec 7;13(12):e0208167
pubmed: 30532210
Health Policy Plan. 2016 Jul;31(6):729-35
pubmed: 26701916
Health Care Women Int. 2017 Sep;38(9):927-944
pubmed: 28586273
J Adolesc Health. 2019 Dec;65(6):730-737
pubmed: 31543406
Glob Soc Welf. 2015 Jun;2(2):87-103
pubmed: 26075159
J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):393-400
pubmed: 23535293
Int J Womens Health. 2017 Sep 28;9:727-737
pubmed: 29033613
J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):53-63
pubmed: 28991885
AIDS. 2017 Jul 01;31 Suppl 3:S195-S201
pubmed: 28665877
J Adolesc Health. 2017 Feb;60(2S2):S15-S21
pubmed: 28109335
Gates Open Res. 2018 Dec 11;2:68
pubmed: 31131368
Am J Public Health. 2009 Dec;99(12):2224-9
pubmed: 19833992
Curr HIV/AIDS Rep. 2015 Jun;12(2):207-15
pubmed: 25855338
AIDS Behav. 2018 Jun;22(6):1858-1869
pubmed: 28161801
Lancet. 2010 Jul 3;376(9734):41-8
pubmed: 20557928
J Adolesc Health. 2015 Jan;56(1 Suppl):S15-21
pubmed: 25528976
J Acquir Immune Defic Syndr. 2016 May 1;72(1):96-104
pubmed: 26825176